BioSkryb Corporation
Latest round
- Seed
Last raised
- Jan 2020
Total raised
- $12M
Investors
- 2
About BioSkryb Corporation
Founded in 2018, BioSkryb Corporation is based in Durham, US, specializing in genomic and transcriptomic amplification solutions. The company was co-founded by Charles Gawad and Jay West.5 mn.BioSkryb Genomics specializes in advanced single-cell analysis technologies that focus on genomic and transcriptomic amplification. Their core offerings include the patented Primary Template-directed Amplification (PTA) and the ResolveOME multiomic analysis platform, enabling simultaneous genome and transcriptome amplification from individual cells. This technology addresses cellular heterogeneity challenges, offering insights into genomic variability crucial for understanding health and disease.BioSkryb Genomics operates a revenue model based on specialized genomic analysis services and products tailored to clients' needs. Client transactions typically occur through direct partnerships with academic and research entities, utilizing BioSkryb's proprietary technologies and bioinformatics platforms for custom genomic analysis and whole-genome amplification. The company aims to enhance its genomic analysis offerings and explore new geographic markets beyond its current focus in North America and Europe, although specific regions and timelines for this expansion have not been disclosed.
Who invested in BioSkryb Corporation
2 investors across 1 round
See all investors in BioSkryb Corporation
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 8, 2020
Amount
$12M
Investors
Questions about BioSkryb Corporation
Who invested in BioSkryb Corporation?
BioSkryb Corporation has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has BioSkryb Corporation raised?
BioSkryb Corporation has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did BioSkryb Corporation last raise money?
BioSkryb Corporation's most recent round on record is a Seed, in Jan 2020.
What does BioSkryb Corporation do?
Founded in 2018, BioSkryb Corporation is based in Durham, US, specializing in genomic and transcriptomic amplification solutions.
Where is BioSkryb Corporation headquartered?
BioSkryb Corporation is headquartered in Durham, US.
Which VCs invest in companies like BioSkryb Corporation?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at BioSkryb Corporation's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like BioSkryb Corporation? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.